Shares of Healthscope tested the $2.10 support level last week.
With the company on track to increase earnings in FY19 & FY20, we see the sell-off as an opportunity to buy the stock before it pushes back through the recent $2.28 high.

Healthscope

Shares of Healthscope tested the $2.10 support level last week.
With the company on track to increase earnings in FY19 & FY20, we see the sell-off as an opportunity to buy the stock before it pushes back through the recent $2.28 high.

Healthscope
Join Investor Signals today and start your journey to better, more disciplined returns.